NCT06362369 2025-09-17A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy7 Hills Pharma, LLCPhase 1/2 Recruiting126 enrolled
NCT06364631 2025-01-16CARE1Gustave Roussy, Cancer Campus, Grand ParisPhase 3 Recruiting1,250 enrolled